Amphastar Pharmaceuticals AMPH Payments For Deposits And Other Assets
Payments For Deposits And Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept amph:PaymentsForDepositsAndOtherAssets.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's payments for deposits and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's payments for deposits and other assets?
- Amphastar Pharmaceuticals (AMPH) reported payments for deposits and other assets of -$67K in Q1 2026.
- How has Amphastar Pharmaceuticals's payments for deposits and other assets changed year-over-year?
- Amphastar Pharmaceuticals's payments for deposits and other assets decreased by 472.2% year-over-year, from $18K to -$67K.
- What is the long-term trend for Amphastar Pharmaceuticals's payments for deposits and other assets?
- Over 3 years (2021 to 2025), Amphastar Pharmaceuticals's payments for deposits and other assets has grown at a 18.6% compound annual growth rate (CAGR), from $2.61M to $4.36M.
- What does payments for deposits and other assets mean?
- This metric tracks cash outflows for security deposits, long-term prepayments, or other non-current assets that do not fall under standard capital expenditures. It reflects the company's allocation of capital toward operational requirements or strategic partnerships that require upfront funding. Monitoring these payments helps identify non-core cash usage that may impact short-term liquidity.